Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
Development of solid cancer depends on escape from host immunosurveillance. Various types of immune cells contribute to tumor-induced immune suppression, including tumor associated macrophages, regulatory T cells, type 2 NKT cells, and myeloid-derived suppressor cells (MDSCs). Growing body of eviden...
Main Authors: | Katoh, Hiroshi, Watanabe, Masahiko |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452485/ |
Similar Items
-
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
by: Wesolowski, Robert, et al.
Published: (2013) -
Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
by: Giallongo, Cesarina, et al.
Published: (2015) -
Myeloid-derived suppressor cells, age and cancer
by: Bowdish, Dawn ME
Published: (2013) -
Myeloid-derived suppressor cells link inflammation to cancer
by: Wang, Dingzhi, et al.
Published: (2014) -
Myeloid-Derived Suppressor Cells in Sepsis
by: Lai, Dengming, et al.
Published: (2014)